FDA asks how to improve existing Regulations
The U.S. Food and Drug Administration FDA announced that the agency is formally asking for submissions on how to improve existing regulations. FDA expects that retrospective reviews like this would help FDA focus on how to improve regulations.
- Where are regulations ineffective?
- Do regulations address current public health challenges?
- Is there a need to update regulations?
- Can regulations be revised in ways that make them less burdensome without making them less effective?
- Are there regulatory requirements that are redundant, inconsistent or needlessly overlap?
To get more information, go to the FDA Transparency Blog.
Related GMP News
01.07.2026EMA publishes updated Q&A on EU-US MRA - Veterinary Medicinal Products now fully covered
24.06.2026Reduced Testing a Matter of GMP or Specification?
17.06.2026FDA adopts updated ICH Q8/Q9/Q10 Questions & Answers (R5)
10.06.2026European QP Association Developments January through April 2026
15.04.2026ICH Q9 Training Package updated